Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration
Conclusions: RPE atrophy progresses in eyes with exudative AMD during anti-VEGF treatment. Larger areas of RPE atrophy at month 4 and larger numbers of anti-VEGF injections were associated with an increased risk of progression of RPE atrophy the following treatment. These findings may be useful to clinicians using intravitreal anti-VEGF for the treatment of exudative AMD, both for selecting an appropriate treatment plan and for predicting the progression of RPE atrophy.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Moosang Kim Eung Suk Kim Kyung Hoon Seo Seung-Young Yu Hyung-Woo Kwak Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study